Diabetes Clinical Trials in Houston

Showing 41-60 of 277 trials

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

NCT05761301

To evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of single ascending doses of ALN-KHK and to evaluate the safety, tolerability, efficacy, PK and PD of multiple doses of KHK.

Type 2 Diabetes Mellitus (T2DM)

Alnylam Pharmaceuticals49 participantsStarted Mar 2023

Phoenix, Arizona, United States • Vista, California, United States • Lake Worth, Florida, United States +12 more locations

COMPLETEDPHASE2< 1 mile

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

NCT02010242

NADPH oxidase enzymes (NOX) have been implicated in the development of several diabetic complications including diabetic nephropathy. GKT137831 is the first in class NOX1/4 inhibitor. The primary objective of this study is to evaluate the efficacy of oral GKT137831 in patients with residual albuminuria despite maximal inhibition of the renin angiotensin aldosterone system.

Type 2 Diabetes Mellitus With Diabetic Nephropathy

Calliditas Therapeutics AB136 participantsStarted Oct 2013

Tucson, Arizona, United States • Orange, California, United States • Coral Gables, Florida, United States +45 more locations

A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

Safety and Efficacy of Oral GKT137831 in Patient With Type 2 Diabetes and Albuminuria

Diabetes Trials in Other Cities

A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Have Not Used Insulin Before (ONWARDS 3)

Veteran Support and Resources for Diabetes

Pilot Study of Brief Intervention to Support Diabetes Health-Related Quality of Life

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

Extended Criteria For Fetal Myelomeningocele Repair

Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM

Safety & Effectiveness of Duodenal Mucosal Resurfacing (DMR) Using the Revita™ System in Treatment of Type 2 Diabetes

Validation Study of RETINA-AI Galaxy™ v2.0, an Automated Diabetic Retinopathy Screening Device

VasQ External Support for Arteriovenous Fistula

Pivotal Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

ACT Intervention for Type 2 Diabetes Management for Rural and Underserved Community

MIRACLE of LIFE Study

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

Safety Evaluation of the Advanced Hybrid Closed Loop (AHCL) System

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

A Study of LY3457263 Alone and in Combination With Dulaglutide (LY2189265) in Participants With Type 2 Diabetes

C-myc Biomarker Study for Diabetic Foot Ulcers

Other Conditions in Houston